Lazzarotto T.; Rizzo R.; Di Luca D.; Gabrielli L.; Guerra B.; Puccetti C.; Capretti M.G.; Lanari M.; Landini M.P., Prenatal diagnosis and prognosis of congenital cytomegalovirus (CMV) infection in pregnant women undergoing a primary CMV infection., in: Abstract book- CMV 2012 - 4th Congenital Cytomegalovirus Conference - San Francisco, 29 Oct. / 2 November, S.FRANCISCO, s.n, 2012, pp. 118 - 119 (atti di: CMV 2012 - 4th Congenital Cytomegalovirus Conference, San Francisco,, 29 Oct. / 2 November) [atti di convegno-abstract]
Capretti, M.G.; Lanari, M.; De Angelis, M.; Marsico, C.; Marangoni, A.; Nardini, P.; Compri, M.; Foschi, C.; Faldella, G., TOXOPLASMA GONDII DNA DETECTION IN GUTHRIE CARDS: A RETROSPECTIVE STUDY, «JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE», 2012, 1, pp. 146 - 146 [abstract]
Simões, Eric A F; Carbonell-Estrany, Xavier; Fullarton, John R; Rossi, Giovanni A; Barberi, Ignazio; Lanari, Marcello, European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data, «THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE», 2011, 24, pp. 152 - 157 [articolo]
Lanari M.; Capretti M.G.; Lazzarotto T., Neuroimaging examinations of newborns in vertically acquired infections., «THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE», 2011, 24, pp. 117 - 119 [articolo]
Lanari M.; Adorni F.; Silvestri M.; Coscia A.; Musicco M.; Faldella G., The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results, «EARLY HUMAN DEVELOPMENT», 2011, 87, pp. S43 - S46 [articolo]
Lazzarotto T.; Guerra B.; Gabrielli L.; Lanari M.; Landini M.P., Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy, «CLINICAL MICROBIOLOGY AND INFECTION», 2011, 17, pp. 1285 - 1293 [articolo]
Lazzarotto T.; Lanari M., Recensione a: Why is cytomegalovirus the most frequent cause of congenital infection?, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2011, 9, pp. 841 - 843 [recensione]
Manzoni, P; Tarnow-Mordi, W; Franco, C; Gallo, E; Spera, A M; Rizzollo, S; Decembrino, L; Stronati, M; Lanari, M; Farina, D, Clinical use of lactoferrin in preterm neonates: an update, «MINERVA PEDIATRICA», 2010, 62, pp. 101 - 104 [articolo]
Resti, Massimo; Moriondo, Maria; Cortimiglia, Martina; Indolfi, Giuseppe; Canessa, Clementina; Becciolini, Laura; Bartolini, Elisa; de Benedictis, Fernando Maria; de Martino, Maurizio; Azzari, Chiara; Italian Group for the, Study of Invasive Pneumococcal Disease; Lanari, M., Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples, «CLINICAL INFECTIOUS DISEASES», 2010, 51, pp. 1042 - 1049 [articolo]
S. Pignatelli; T. Lazzarotto; MR. Gatto; P. Dal Monte; MP.Landini; G. Faldella; M. Lanari, Cytomegalovirus gN Genotypes Distribution among Congenitally Infected Newborns and Their Relationship with Symptoms at Birth and Sequelae., «CLINICAL INFECTIOUS DISEASES», 2010, 51, pp. 33 - 41 [articolo]
Lanari, M; Capretti, M G; Decembrino, L; Natale, F; Pedicino, R; Pugni, L; Serra, L, Focus on pandemic 2009 H1N1 influenza (swine flu), «MINERVA PEDIATRICA», 2010, 62, pp. 39 - 40 [articolo]
Berardi, Alberto; Lugli, Licia; Baronciani, Dante; Rossi, Cecilia; Ciccia, Matilde; Creti, Roberta; Gambini, Lucia; Mariani, Sabrina; Papa, Irene; Tridapalli, Elisabetta; Vagnarelli, Federica; Ferrari, Fabrizio; Prevention Working Group of Emilia-Romagna, Gbs; Lanari, M., Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach, «THE PEDIATRIC INFECTIOUS DISEASE JOURNAL», 2010, 29, pp. 115 - 121 [articolo]
Faldella G; Alessandroni R; Aquilano G; Vandini S; Lanari M; Silvestri M; Pastorio A; Rossi GA., Hospitalization for lower respiratory tract disease in preterm infants: effects of prophylaxis with palivizumab., «JOURNAL OF CHEMOTHERAPY», 2010, 22, pp. 30 - 35 [articolo]
Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Faldella G; Motavizumab Study Group [; Lanari M; ], Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial., «PEDIATRICS», 2010, 125, pp. e35 - e51 [articolo]
Lanari, Marcello; Silvestri, Michela; Rossi, Giovanni A, Palivizumab prophylaxis in 'late preterm' newborns, «THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE», 2010, 23 Suppl 3, pp. 53 - 55 [articolo]
